Among patients with resectable non-small cell lung cancer, Opdivo plus Yervoy has displayed potential long-term clinical ...
The researchers found that factors favoring chemoimmunotherapy included higher socioeconomic status, being uninsured, a more ...
Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have ...
People who land in the ER after using hallucinogens are more than twice as likely to die in a handful of years, a new study ...
People who land in the ER after using hallucinogens are more than twice as likely to die in a handful of years, a new ...
A woman with terminal lung cancer has said she feels "scared" of dying at home rather than in the care of a specialist ...
More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a ...
WHEN Kerrie Mitchell found a lump just beneath her neck, she never imagined it could be lung cancer. For at 46, the busy working mum felt as fit as a fiddle and brushed the thought of it aside ...
For terminally ill cancer patients, the final days of life are immensely personal, having the choice to continue cancer ...
Although overall cancer mortality rates are declining for Black patients, they continue to have higher mortality rates than White patients for some cancers.
The American people have consistently supported life-saving cancer research. Now the nation’s bedrock source of public ...
Dr. Bryant Lin, who teaches medicine at Stanford University, was given a terminal diagnosis. He wanted his students to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback